Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria
Expected data in H2 2022 brings Synlogic to three clinical readouts this year
Third candidate in less than two years to enter the clinic; Reflects productivity of Synthetic Biotic platform
CAMBRIDGE, Mass., July